The FDA has expanded its approval of Imfinzi® (durvalumab), to include stage III non-small cell lung cancer patients. The immunotherapy was approved for bladder cancer last year, but Moffitt’s Dr. Scott Antonia saw the potential of Imfinzi as a treatment option for lung cancer patients. He launched a global clinical trial with more than 700 patients and found the therapy made a big difference in survival for this group of patients. http://ow.ly/bwij30ivPPd | Moffitt Cancer Center
0:34
The FDA has expanded its approval of Imfinzi® (durvalumab), to includ…
4.7K viewsFeb 20, 2018
FacebookMoffitt Cancer Center
Side Effects of Immunotherapy: What to Know
2:34
Side Effects of Immunotherapy: What to Know
5 months ago
cancerresearch.org
Dr. Feldman on Durvalumab for Patients With Lung Cancer | OncLive
Dr. Feldman on Durvalumab for Patients With Lung Cancer | OncLi…
Nov 9, 2017
onclive.com
149K views · 680 reactions | Diagnosed with stage 4 lung cancer, K.c. Ashabranner Dill's outlook was not positive. But after being treated with immunotherapy at Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, her cancer disappeared – recent scans show no evidence of the disease. #CIM18 | Cancer Research Institute | Facebook
0:22
149K views · 680 reactions | Diagnosed with stage 4 lung canc…
149.8K views3 weeks ago
FacebookCancer Research Institute
Immunotherapy Side Effects: When to Call Your Doctor
Immunotherapy Side Effects: When to Call Your Doctor
Feb 29, 2024
WebMDStephanie Booth
5.7K views · 53 reactions | Immunotherapy Nightmare - Imfinzi/Durvalumab Experience - Lung Cancer The purpose of this page is to document Jenny cancer journey to look back on, and/or help anyone else going through anything similar. It is also to potentially help loved ones supporting those who are in this fight as well. Thank you so much for following along on this journey. Your love and support help me so much. | Jenny Appleford | Facebook
52:55
5.7K views · 53 reactions | Immunotherapy Nightmare - Imfin…
2.4K views2 weeks ago
FacebookJenny Appleford
9.2K views · 46 reactions | No new advances in systemic treatments for limited-stage small-cell lung cancer have been made for decades. Research findings on adjuvant therapy with durvalumab are summarized in a new Quick Take video. https://nej.md/4d0eZ5m | The New England Journal of Medicine | Facebook
2:08
9.2K views · 46 reactions | No new advances in systemic treatments f…
1.7K views1 week ago
FacebookThe New England Journal of Medicine
PD-L1, PD1,TMB and Lung Cancer
1 month ago
lung.org
Treating for Stage III NSCLC After Progression on Durvalumab | Onc…
Jul 13, 2020
onclive.com
2:30
7.7K views · 52 reactions | In patients with muscle-invasive blad…
1.7K views1 week ago
FacebookThe New England Journal of Medicine
Durvalumab ± Tremelimumab Chemotherapy in First-Line Metast…
Feb 26, 2024
onclive.com
Dr. Langer on the Benefit of Durvalumab in Stage III NSCLC | O…
May 29, 2019
onclive.com
26:06
13K views · 354 reactions | The Apple Family Life Update-Life Afte…
13.1K views1 week ago
FacebookJenny Appleford
3:26
Immunotherapy Advances in SCLC: Unlocking Treatment Potential
2 months ago
YouTubeThe Shared Voice
5:24
Imfinzi Approved: A New Era in Gastric Cancer Immunotherapy
1 month ago
YouTubeEndless Possibilities
5:12
Immunotherapy for Small Cell Lung Cancer: Recent Advances and Fut…
2 months ago
YouTubeUniversal Content Space
0:51
Marcel D’Allende survived Lung Cancer | carboplatin | pemetrexed …
794 views1 month ago
YouTubeCancer Interviews
5:51
Immunotherapy Breakthroughs in SCLC: What You Need to Know
2 months ago
YouTubeThe Open Forum
3:44
Immunotherapy Advances in SCLC: Highlighting Promise, Limitations…
1 month ago
YouTubeEcho Sphere
4:04
Immunotherapy Advances in SCLC: What You Need to Know
2 months ago
YouTubeVoices Without Borders
5:34
Immunotherapy Advances in SCLC: What We Know and What's Next
1 views2 months ago
YouTubeTimeless Connection
0:08
GO2 for Lung Cancer on Instagram: "📢 The @fda has approved Imfinzi (…
581 viewsDec 6, 2024
Instagramgo2forlungcancer
2:04
Neoadjuvant Nivolumab in Resectable Lung Cancer | NEJM
6.8K viewsMay 26, 2022
YouTubeNEJM Group
42:48
Immunotherapy for Lung Cancer
14.7K viewsJan 18, 2016
YouTubeGlobal Resource for Advancing Cancer Education
2:12
Cancer immunotherapy | The PD-L1 pathway
214.2K viewsMay 26, 2016
YouTubeRoche
1:16
Explaining Immunotherapy, PD-L1 and PD-1
39.4K viewsSep 14, 2020
YouTubeAmerican Lung Association
3:46
Understanding Immunotherapy for Lung Cancer
36.2K viewsAug 6, 2020
YouTubeYou and Lung Cancer
27:08
Immunotherapy Advances in Small Cell Lung Cancer
35.1K viewsNov 28, 2018
YouTubeCancer Research Institute
3:12
Opdivo (nivolumab) the Immunotherapy Cancer Treatment
79.3K viewsJun 3, 2016
YouTubeOncology Associates
4:28
Living Well With Stage 4 Lung Cancer
158.5K viewsSep 16, 2015
YouTubeAmerican Association for Cancer Research
See more videos
Static thumbnail place holder